News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Repros Therapeutics Inc. (RPRX) Announces Formation of Androxal® Clinical and Commercial Advisory Board



7/10/2013 9:16:43 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, July 9, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced the formation of an international, multi-disciplinary, clinical advisory board to help maximize the commercial opportunity for Androxal.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES